Published On: December 17th, 2009
The cholesterol drugs known as statins are already wildly popular; now it looks like the use of one statin could be expanded to treat people with normal cholesterol levels.
An FDA advisory committee yesterday recommended using AstraZeneca’s Crestor to reduce the risk of heart disease in certain patients with normal cholesterol levels but elevated levels of something called c-reactive protein, or CRP. Here’s a story from Dow Jones Newswires.
CRP is a measure of inflammation; a big study showed that Crestor lowered the risk of serious heart trouble for people with elevated CRP and normal cholesterol (though it also appeared to increase the risk of diabetes).
As we noted last week, measuring CRP levels isn’t a standard part of looking at patients’ heart-disease risk. But if the FDA follows the committee’s advice and approves Crestor for this indication, screening patients for CRP could become more common.
Photo by CarbonNYC via Flickr

See the rest here:
The Cholesterol Drug for People Without High Cholesterol



Did you know:






